Kenji Kita
5PUBLICATIONS
25CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jan 14, 2022
Heterogeneity among tumors with acquired resistance to EGFR tyrosine kinase inhibitors harboring EGFR-T790M mutation in non-small cell lung cancer cells.Yuki Katayama, Tadaaki Yamada, Shinsaku Tokuda
|Apr 02, 2021
FOXO3 is a latent tumor suppressor for FOXO3-positive and cytoplasmic-type gastric cancer cells.Toshikatsu Tsuji, Yusuke Maeda, Kenji Kita
|Sep 15, 2020
Transient IGF-1R inhibition combined with osimertinib eradicates AXL-low expressing EGFR mutated lung cancer.Rong Wang, Tadaaki Yamada, Kenji Kita
|Aug 22, 2019
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance.Kenji Kita, Koji Fukuda, Hiro Takahashi
|Nov 11, 2017
In vivo imaging xenograft models for the evaluation of anti-brain tumor efficacy of targeted drugs.Kenji Kita, Sachiko Arai, Akihiro Nishiyama
Pageof 1
Frequent Collaborators
2 joint publications
Seiji Yano
2 joint publications
Tadaaki Yamada
1 joint publications
Atsushi Tajima
1 joint publications
Hiro Takahashi
1 joint publications
Rong Wang
1 joint publications
Hirokazu Taniguchi
1 joint publications
Minoru Terashima
1 joint publications
Akihiko Ishimura
1 joint publications
Azusa Tanimoto
1 joint publications
Shinji Takeuchi
